Objective: To determine the safety and efficacy of a new gel formulation of podofilox in the treatment of anogenital warts.
Design: Double-blind, randomized, multicenter, vehicle-controlled investigation.
Setting: Private dermatology practices, university clinics (dermatology, gynecology, and infectious diseases), and contract research organizations.